RKLIF (Rentokil Initial) Research & Development: $0 Mil (TTM As of Dec. 2025)


RKLIF Rentokil Initial PLC RKLIF
88 GF Score
Price $5.93
GF Value $6.25
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Rentokil Initial Research & Development?

Rentokil Initial RKLIF 88 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates RKLIF with a GF Score™ of 88/100 and a GF Value™ of $6.25 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rentokil Initial's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

Rentokil Initial  (OTCPK:RKLIF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rentokil Initial Research & Development Related Terms

Rentokil Initial Research & Development Historical Data

* Premium members only.

The historical data trend for Rentokil Initial's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rentokil Initial Research & Development Chart

Rentokil Initial Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Rentokil Initial Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RKLIF
88GF Score
Rentokil Initial PLC RKLIF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rentokil Initial Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Rentokil Initial (RKLIF) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Rentokil Initial and its competitors.
Is Rentokil Initial's Research & Development too high?
Rentokil Initial's current Research & Development is $0 Mil. Overall, Rentokil Initial has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rentokil Initial's Research & Development compare to CTAS and CPRT?
Rentokil Initial's Research & Development of $0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rentokil Initial and its competitors. Rentokil Initial's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rentokil Initial stock overvalued right now?
Based on GuruFocus' analysis, Rentokil Initial (RKLIF) is currently considered Fairly Valued. The stock's GF Value™ is $6.25, compared to a current price of $5.93 — trading 5.1% below its estimated fair value. The current Research & Development is $0 Mil. Rentokil Initial's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rentokil Initial (RKLIF), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rentokil Initial (RKLIF) Overvalued in 2026?

Based on GuruFocus' analysis, Rentokil Initial stock appears to be undervalued. The current stock price of $5.93 is trading 5.1% below its estimated GF Value™ of $6.25. GuruFocus considers Rentokil Initial to be Fairly Valued.

Key valuation signals for RKLIF:

  • Research & Development: $0 Mil
  • GF Value™: $6.25 vs. price of $5.93 (5.1% below fair value)
  • GF Score™: 88/100 with 6 warning signs

No single metric tells the full story. See the RKLIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rentokil Initial Business Description

Address Manor Royal, Compass House, Crawley, West Sussex, GBR, RH10 9PY
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
88GF Score

Get the complete analysis for RKLIF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.93
Price
$6.25
GF Value